Commercialization of catalytic enhancers targeting IDO1 for multiple sclerosis

Project description

A novel drug against multiple sclerosis

Fields of science

• medical and health sciences › basic medicine › neurology › multiple sclerosis
• medical and health sciences › basic medicine › immunology › autoimmune diseases

Programme(s)

• H2020-EU.1.1. - EXCELLENT SCIENCE - European Research Council (ERC)

Topic(s)

• ERC-2019-POC - ERC Proof of Concept Grant

Call for proposal

ERC-2019-PoC
See other projects for this call

Funding Scheme

ERC-POC-LS - ERC Proof of Concept Lump Sum Pilot

Host institution

UNIVERSITA DEGLI STUDI DI PERUGIA

Address

Piazza Dell Universita 1
06123 Perugia
Italy

Activity type

Higher or Secondary Education Establishments

EU contribution

€ 150 000

Beneficiaries (1)

UNIVERSITA DEGLI STUDI DI PERUGIA

Italy

EU contribution

€ 150 000

Address

Piazza Dell Universita 1
06123 Perugia

Activity type

Higher or Secondary Education Establishments